For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pulmonx Corp (NASDAQ: LUNG) closed the day trading at $6.91 down -2.12% from the previous closing price of $7.06. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 0.9 million shares were traded. LUNG stock price reached its highest trading level at $7.1148 during the session, while it also had its lowest trading level at $6.66.
Ratios:
For a better understanding of LUNG, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.13 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on June 04, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On February 23, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $16 to $14.
On September 05, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $18.Craig Hallum initiated its Buy rating on September 05, 2023, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 24 ’24 when Rose Geoffrey Beran sold 1,184 shares for $6.16 per share. The transaction valued at 7,293 led to the insider holds 300,019 shares of the business.
Lehman David Aaron sold 5,475 shares of LUNG for $38,161 on Jun 03 ’24. The GENERAL COUNSEL now owns 209,113 shares after completing the transaction at $6.97 per share. On Jun 03 ’24, another insider, Rose Geoffrey Beran, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 4,297 shares for $6.97 each. As a result, the insider received 29,950 and left with 301,203 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LUNG now has a Market Capitalization of 268217168 and an Enterprise Value of 198481264. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 2.43. Its current Enterprise Value per Revenue stands at 2.719 whereas that against EBITDA is -3.391.
Stock Price History:
Over the past 52 weeks, LUNG has reached a high of $14.84, while it has fallen to a 52-week low of $5.67. The 50-Day Moving Average of the stock is -3.34%, while the 200-Day Moving Average is calculated to be -28.41%.
Shares Statistics:
Over the past 3-months, LUNG traded about 392.49K shares per day on average, while over the past 10 days, LUNG traded about 374240 shares per day. A total of 38.52M shares are outstanding, with a floating share count of 35.12M. Insiders hold about 9.52% of the company’s shares, while institutions hold 90.11% stake in the company. Shares short for LUNG as of 1721001600 were 1289294 with a Short Ratio of 3.28, compared to 1718323200 on 1398933. Therefore, it implies a Short% of Shares Outstanding of 1289294 and a Short% of Float of 4.7399998.
